Putney Financial Group LLC Takes Position in Danaher Co. (NYSE:DHR)

Putney Financial Group LLC purchased a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 3,774 shares of the conglomerate's stock, valued at approximately $866,000. Danaher makes up approximately 0.6% of Putney Financial Group LLC's investment portfolio, making the stock its 23rd biggest position.

Several other large investors have also bought and sold shares of DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the fourth quarter worth approximately $27,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the 4th quarter worth $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher during the fourth quarter worth $31,000. Pineridge Advisors LLC raised its stake in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 57 shares in the last quarter. Finally, Kentucky Trust Co bought a new position in shares of Danaher in the fourth quarter valued at approximately $34,000. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Royal Bank of Canada reissued an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Wall Street Zen cut shares of Danaher from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. JPMorgan Chase & Co. cut their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Finally, Raymond James reiterated a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $263.24.

Insider Transactions at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company's stock.

Danaher Stock Performance

Shares of DHR stock traded up $1.37 during trading on Thursday, reaching $190.38. 2,814,458 shares of the company's stock were exchanged, compared to its average volume of 3,470,766. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The firm's fifty day moving average price is $193.63 and its 200-day moving average price is $214.49. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $136.25 billion, a PE ratio of 36.06, a PEG ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, sell-side analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.67%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.